Global public-private partners
Joined February 2015
- Tweets607
- Following86
- Followers506
- Likes94
'Vaccine uptake among children in England has fallen since start of pandemic.' Bad news for #AMR? theguardian.com/society/2023…
DRIVE-AB retweeted
Are you following our @jac_amr account yet? Our fully #OpenAccess journal is the best place for all things related to #AMR and #AntibioticStewardship!
Look at #AMR from a different perspective🔎
Our FREE course, Tackling Antimicrobial Resistance: A Social Science Approach, explores how different cultures, customs and habits should all be considered to help #stopsuperbugs
Registration open now! futurelearn.com/courses/soci…
DRIVE-AB retweeted
Our @DRIVE_AB project's final report recommends a mix of push & pull incentives to stimulate #antibiotic development.
Read the report bit.ly/driveab
Read the project's press release bit.ly/2ruChiq
#AntimicrobialResistance #CarryTheTorch #InvestEUresearch
ALT The incentives identified by the project are: grants, pipeline coordinators, market entry rewards, long-term supply continuity model.
DRIVE-AB consortium publishes final report on revitalizing the antibiotic pipeline, available at drive-ab.eu/drive-ab-outputs…
DRIVE-AB retweeted
Want to meet #AMR experts to discuss how to further support #SME-driven innovation in the fight against #AntibioticResistance? Register now for #BerlinConference in March 2018: berlin-conferences.com/home/ @UU_University @BachmannTill @EdinburghUni @DRIVE_AB @ND4BB_ENABLE
A very concise summary of 4 recommended incentives from @DRIVE_AB to drive antibiotic R&D xitter.cf/JohnRex_NewAbx/status/…
I've posted my slide summary of DRIVE-AB's 4 recommended incentives: grants, pipeline coordination, MERs, continuity amr.solutions/blog/summary-o…
DRIVE-AB retweeted
@DRIVE_AB has worked for 3 years to design antibiotic pull incentives - we need these to be implemented quickly
On behalf of @DRIVE_AB - a big thank you to all of the delegates & participants who made the #DRIVEAB2017 conference this week a success!
Full details of @DRIVE_AB recommendations will be available with our final report January 2018 xitter.cf/damidefelice/status/90…
How should a market entry reward for new antibiotics look like? David Findlay @GSK presents the recommendations from @DRIVE_AB. #DRIVEAB2017
DRIVE-AB retweeted
How should a market entry reward for new antibiotics look like? David Findlay @GSK presents the recommendations from @DRIVE_AB. #DRIVEAB2017
DRIVE-AB retweeted
Incredible news for the global campaign against #AntibioticResistance #AMR @DRIVE_AB @DukeGHI @CIDRAP_ASP xitter.cf/koutterson/status/9050…
The final panel kicks off - what is the way forward and how do we get there? #DRIVEAB2017
'How do we change the net present value calculation of antibiotics in pharma to improve prioritization and decision making?' Steve Projan
Lively, informative discussions on this panel about MER vs value-based pricing and how to solve the broken market #DRIVEAB2017
Gregory Daniel from @dukemargolis tells us about their work looking at model options in the US
"Market entry rewards need be targeted, sustainable, transparent, and sufficient." #DRIVEAB2017
David Findlay starts off the afternoon session of #DRIVEAB2017 by wading into the thick of it - the details of our recommended options
EC, BARDA, Wellcome, ENABLE, & Helmholtz Center coming together at #DRIVEAB2017 to discuss how to ensure sustainable innovation
DRIVE-AB retweeted
How can young people help tackle antibiotic resistance?Join us at #Expo17NHS next week and we'll explain all: ow.ly/scmH30eMKSH #AMR
